Biotinylated Human NKG2C/CD159c Protein
Beta LifeScience
SKU/CAT #: BLK-01029P-100UG

Biotinylated Human NKG2C on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human NKG2C/CD159c Protein
Beta LifeScience
SKU/CAT #: BLK-01029P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human NKG2C/CD159c Protein is expressed from HEK293 with His tag and Avi tag at the N-Terminus.It contains Glu98-Leu231. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P26717 |
Target Symbol | NKG2C/CD159c |
Species | Human |
Expression System | HEK293 |
Tag | N-His-Avi |
Expression Range | Glu98-Leu231 |
Mol. Weight | The protein has a predicted MW of 15.3 kDa. Due to glycosylation, the protein migrates to 35-55 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections.The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness. |